Global Gastrointestinal Partnering 2010-2016: Deal trends, players and financials

Published: November 2016
No. of Pages: 700
    ReportsandReports

“Delivery of this report will take 1-3 days after purchase.”

Global Gastrointestinal Partnering 2010 to 2016 provides the full collection of Gastrointestinal disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Trends in Gastrointestinal partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Gastrointestinal partnering agreement structure
Gastrointestinal partnering contract documents
Top Gastrointestinal deals by value
Most active Gastrointestinal dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Gastrointestinal disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gastrointestinal deals.

The report presents financial deal terms values for Gastrointestinal deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Gastrointestinal dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Gastrointestinal dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Gastrointestinal deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Gastrointestinal dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Gastrointestinal deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Gastrointestinal partnering deals by specific Gastrointestinal target announced since 2010. The chapter is organized by specific Gastrointestinal therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Gastrointestinal partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Gastrointestinal partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Gastrointestinal technologies and products.

Report scope

Global Gastrointestinal Partnering 2010 to 2016 is intended to provide the reader with an in-depth understanding and access to Gastrointestinal trends and structure of deals entered into by leading companies worldwide.

Global Gastrointestinal Partnering 2010 to 2016 includes:

Trends in Gastrointestinal dealmaking in the biopharma industry since 2010
Analysis of Gastrointestinal deal structure
Access to headline, upfront, milestone and royalty data
Access to hundreds of Gastrointestinal deal contract documents
Comprehensive access to over 3500 Gastrointestinal deal records
The leading Gastrointestinal deals by value since 2010
Most active Gastrointestinal dealmakers since 2010

The report includes deals for the following indications: Appendicitis, Celiac disease, Esophageal reflux, Esophagitis, Gastritis, Gastroenteritis, Hemorrhoids (haemorrhoids), Hernia, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Irritable bowel syndrome, Malabsorption, Malnutrition, Pancreatitis, Peptic ulce, Gastric ulcer, Duodenal ulcer, Abdominal pain, Ascites, Bowel movement, Constipation, Diarrhea, Jaundice, Vomitting, plus other gastrointestinal indications.

In Global Gastrointestinal Partnering 2010 to 2016, available deals and contracts are listed by:

Headline value
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Technology type
Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Gastrointestinal Partnering 2010-2016 report provides comprehensive access to available deals and contract documents for over 400 gastrointestinal deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are the sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

Global Gastrointestinal Partnering 2010 to 2016 provides the reader with the following key benefits:

In-depth understanding of Gastrointestinal deal trends since 2010
Access Gastrointestinal deal headline, upfront, milestone and royalty data
Research hundreds of actual contracts between Gastrointestinal partner companies
Comprehensive access to over 750 links to actual Gastrointestinal deals entered into by the world’s biopharma companies
Indepth review of Gastrointestinal deals entered into by the top 25 most active dealmakers
Benchmark the key deal terms companies have agreed in previous deals
Identify key terms under which companies partner Gastrointestinal opportunities
Uncover companies actively partnering Gastrointestinal opportunities

Published By: Current Partnering
Product Code: Current Partnering547


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • Global Circulating Tumor Cells Market by Manufacturers, Regions, Type and Application, Forecast to 2021

    This report mainly covers Circulating Tumor Cells products, by types (CTC enrichment, CTC detection and CTC analysis), by applications (Prostate Cancer, Breast Cancer, Colorectal Cancer Diagnosis and Treatment and Others). Scope of the Report: T...

  • Global Cephalosporin Drugs Market Research Report 2016

    Notes: Production, means the output of Cephalosporin Drugs Revenue, means the sales value of Cephalosporin Drugs This report studies Cephalosporin Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and Indi...

  • Global Blood Serum Market Research Report 2016

    Notes: Production, means the output of Blood Serum Revenue, means the sales value of Blood Serum This report studies Blood Serum in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufa...

  • Global Biotherapeutics Cell Line Development Market Research Report 2016

    Notes: Production, means the output of Biotherapeutics Cell Line Development Revenue, means the sales value of Biotherapeutics Cell Line Development This report studies Biotherapeutics Cell Line Development in Global market, especially in North ...

  • Global Biotherapeutics Market Research Report 2016

    Notes: Production, means the output of Biotherapeutics Revenue, means the sales value of Biotherapeutics This report studies Biotherapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses o...

  • Global Bio-pharma Market Research Report 2016

    Notes: Production, means the output of Bio-pharma Revenue, means the sales value of Bio-pharma This report studies Bio-pharma in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufactu...

  • Global Bio-Electronic Medicine Market Research Report 2016

    Notes: Production, means the output of Bio-Electronic Medicine Revenue, means the sales value of Bio-Electronic Medicine This report studies Bio-Electronic Medicine in Global market, especially in North America, Europe, China, Japan, Southeast A...

  • Global Asthma Treatment Drugs Market Research Report 2016

    Notes: Production, means the output of Asthma Treatment Drugs Revenue, means the sales value of Asthma Treatment Drugs This report studies Asthma Treatment Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia...

  • Global Human Fibrin Sealant Market Research Report 2016

    Notes: Production, means the output of Human Fibrin Sealant Revenue, means the sales value of Human Fibrin Sealant This report studies Human Fibrin Sealant in Global market, especially in North America, Europe, China, Japan, Southeast Asia and I...

  • Global Animal Antimicrobials Market Research Report 2016

    Notes: Production, means the output of Animal Antimicrobials Revenue, means the sales value of Animal Antimicrobials This report studies Animal Antimicrobials in Global market, especially in North America, Europe, China, Japan, Southeast Asia an...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: